Madrigal Drug Patent Portfolio
Madrigal owns 1 orange book drug protected by 6 US patents Given below is the list of Madrigal's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12377104 | 04 Feb, 2045 | Active | |
| US10376517 | Methods of synthesizing thyroid hormone analogs and polymorphs thereof | 17 Sep, 2033 | Active |
| US11564926 | Methods of synthesizing thyroid hormone analogs and polymorphs thereof | 17 Sep, 2033 | Active |
| US11986481 | Method of synthesizing thyroid hormone analogs and polymorphs thereof | 17 Sep, 2033 | Active |
| US9266861 | Method of synthesizing thyroid hormone analogs and polymorphs thereof | 17 Sep, 2033 | Active |
| US7452882 | Thyroid hormone analogs | 12 Sep, 2026 | Active |
Latest Legal Activities on Madrigal's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Madrigal.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Second letter to regulating agency to determine regulatory review period | 19 Aug, 2025 | US7452882 |
| Second letter to regulating agency to determine regulatory review period | 19 Aug, 2025 | US9266861 |
| Information Disclosure Statement (IDS) Filed | 12 Aug, 2025 | US7452882 |
| Recordation of Patent Grant Mailed | 12 Aug, 2025 | US12377104 |
| Letter from FDA or Dept of Agriculture re PTE application | 12 Aug, 2025 | US9266861 |
| Letter from FDA or Dept of Agriculture re PTE application | 12 Aug, 2025 | US7452882 |
| Email Notification | 07 Aug, 2025 | US12377104 |
| PG-Pub Issue Notification | 07 Aug, 2025 | US12377104 |
| Email Notification | 05 Aug, 2025 | US12377104 |
| Patent eGrant Notification | 05 Aug, 2025 | US12377104 |
| Patent Issue Date Used in PTA Calculation | 05 Aug, 2025 | US12377104 |
| Mail Patent eGrant Notification | 05 Aug, 2025 | US12377104 |
| Recordation of Patent eGrant | 05 Aug, 2025 | US12377104 |
| Email Notification | 24 Jul, 2025 | US12377104 |
| Issue Notification Mailed | 23 Jul, 2025 | US12377104 |
Madrigal's Family Patents
Madrigal Drug List
Given below is the complete list of Madrigal's drugs and the patents protecting them.
1. Rezdiffra
Rezdiffra is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12377104 |
04 Feb, 2045
(18 years from now)
| Active | |
| US10376517 | Methods of synthesizing thyroid hormone analogs and polymorphs thereof |
17 Sep, 2033
(7 years from now)
| Active |
| US11564926 | Methods of synthesizing thyroid hormone analogs and polymorphs thereof |
17 Sep, 2033
(7 years from now)
| Active |
| US11986481 | Method of synthesizing thyroid hormone analogs and polymorphs thereof |
17 Sep, 2033
(7 years from now)
| Active |
| US9266861 | Method of synthesizing thyroid hormone analogs and polymorphs thereof |
17 Sep, 2033
(7 years from now)
| Active |
| US7452882 | Thyroid hormone analogs |
12 Sep, 2026
(5 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rezdiffra's drug page